Cytocast
Techbio startup using AI-powered predictive modeling to evaluate drug side effects of chemical compounds.
Where Cytocast ranks
Current edition · updated Oct 20, 2026About Cytocast
Techbio startup using AI-powered predictive modeling to evaluate drug side effects of chemical compounds.
Products
High-performance computing platform using a particle-based stochastic simulation algorithm to replicate protein interactions within a virtual cell, integrating drug data and mul...
Clusters hundreds to thousands of compounds and flags potential side-effect liabilities, enabling rapid fail-fast decisions and earlier elimination of weaker candidates before s...
Refines candidate selection during early and late-phase preclinical studies with adverse event analyses and comparative analyses, delivering mechanistic explanations for predict...
Selects lead and backup candidates with interactive reports quantifying adverse-event risk profiles; offers optional drug–drug interaction predictions and safety profile compari...
Security and compliance
No security details published yet
Cytocast hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Cytocast